Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats

Nanjoo Suh, Bandaru S. Reddy, Andrew DeCastro, Shiby Paul, Hong Jin Lee, Amanda K. Smolarek, Jae Young So, Barbara Simi, Chung Xiou Wang, Naveena B. Janakiram, Vernon Steele, Chinthalapally V. Rao*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

61 Scopus citations

Fingerprint

Dive into the research topics of 'Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats'. Together they form a unique fingerprint.

Medicine & Life Sciences